Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 1
2014 2
2015 1
2016 1
2021 1
2023 3
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact.
Ziehfreund S, Saak M, Schaal A, Mazilu R, Mahé E, Hajj C, Johansson EK, Lysell J, Sigurdardottir G, Legat FJ, Koch C, Schmieder A, Glatzel C, Kirby B, Pender E, Zalewska-Janowska A, Tomaszewska K, Ciccarese G, Lauriola P, Boffa MJ, Farrugia S, Pilz AC, Schauer F, Trzeciak M, Zysk W, Gáspár K, Szegedi A, Damiani G, Carugno A, Hartmane I, Mikazans I, Valiukeviciene S, Petrokaite L, Szepietowski JC, Jastrząb B, Staubach P, Hadžavdić SL, Buzina DŠ, Posch C, Jochmann J, Wiala A, Scheffenbichler L, Trovato E, Calabrese L, Fekete GL, Chernyshov P, Kolodzinska L, Welzel J, Thölken K, Maul JT, Maul LV, Meyersburg D, Bowe S, Connor CO, Darlenski R, Traidl S, Vestergaard C, Pinto-Pulido EL, Konstantinou MP, Szlávicz E, Heidemeyer K, Yawalkar N, Lantzsch HAC, Soplinska A, Seitz AT, Torres T, Brzoza Z, Vučemilović AS, Manolache L, Magnolo N, Scala E, Eyerich K, Biedermann T, Zink A. Ziehfreund S, et al. Among authors: mikazans i. J Eur Acad Dermatol Venereol. 2025 Dec 14. doi: 10.1111/jdv.70245. Online ahead of print. J Eur Acad Dermatol Venereol. 2025. PMID: 41392516
Secukinumab improves the signs and symptoms of moderate-to-severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double-blind, placebo-controlled, phase 2 dose-ranging study.
Sigurgeirsson B, Kircik L, Nemoto O, Mikazans I, Haemmerle S, Thurston HJ, Papavassilis C, Richards HB. Sigurgeirsson B, et al. Among authors: mikazans i. J Eur Acad Dermatol Venereol. 2014 Aug;28(8):1127-9. doi: 10.1111/jdv.12343. Epub 2013 Dec 13. J Eur Acad Dermatol Venereol. 2014. PMID: 24330415 Clinical Trial. No abstract available.
13 results